| ADAM10 | A disintegrin and metalloproteinase 10 |
| CAF | Cancer-associated fibroblasts |
| CCL | CC motif chemokine ligand |
| CCR | CC motif chemokine receptor |
| CX3CL1 | CX3C chemokine ligand 1 |
| CX3CR1 | CX3C chemokine receptor 1 |
| CXCL | CXC motif chemokine ligand |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial-to-mesenchymal transition |
| ERK | Extracellular signal-regulated kinase |
| FAK | Focal adhesion kinase |
| GBM | Glioblastoma multiforme |
| HCMV | Human cytomegalovirus |
| HIF-1α | Hypoxia inducible factor-1α |
| IFN-γ | Interferon-γ |
| IL-1β | Interleukin 1β |
| MAPK | Mitogen-activated protein kinase |
| mCX3CL1 | Membrane attached form of CX3CL1 |
| MMP | Matrix metalloproteinase |
| NF-κB | Nuclear factor κB |
| PI3K | Phosphatidylinositol-4,5-bisphosphate 3-kinase |
| sCX3CL1 | Soluble form of CX3CL1 |
| Sp1 | Specificity protein 1 |
| TACE/ADAM17 | Tumor necrosis factor-α converting enzyme/a disintegrin and metalloproteinase 17 |
| TAM | Tumor-associated macrophages |
| TGF-β | Transforming growth factor β |
| TNF-α | Tumor necrosis factor α |
| Treg | Regulatory T cells |
| VEGF | Vascular endothelial growth factor |